New study aims to improve prostate cancer detection for trans community

NCT ID NCT06987045

Recruiting now Knowledge-focused Sponsor: Queen Mary University of London Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is figuring out what normal PSA levels are for trans women and non-binary people who have a prostate. Researchers will measure PSA in 500 volunteers aged 40 and older who are on hormones or have had lower surgery. The goal is to help doctors better detect prostate cancer in this group.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could establish normal PSA ranges for trans women and non-binary people, helping doctors detect prostate cancer earlier in this group.
What could go wrong: This is an observational study, not a treatment trial. It may not change clinical practice immediately, and results depend on the specific group studied.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROSTATE CA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

prostate cancer prostate carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PROSTATE CA

Contacts and locations

Locations

Ambrose King Centre, Barts Health NHS Trust
RECRUITING

London, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.